JP2022543555A5 - - Google Patents
Info
- Publication number
- JP2022543555A5 JP2022543555A5 JP2022505487A JP2022505487A JP2022543555A5 JP 2022543555 A5 JP2022543555 A5 JP 2022543555A5 JP 2022505487 A JP2022505487 A JP 2022505487A JP 2022505487 A JP2022505487 A JP 2022505487A JP 2022543555 A5 JP2022543555 A5 JP 2022543555A5
- Authority
- JP
- Japan
- Prior art keywords
- mirna
- composition according
- cancer
- pten
- source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19191222 | 2019-08-12 | ||
| EP19191222.9 | 2019-08-12 | ||
| EP20160235.6 | 2020-02-28 | ||
| EP20160235 | 2020-02-28 | ||
| PCT/EP2020/055965 WO2021028081A1 (en) | 2019-08-12 | 2020-03-06 | New treatments involving mirna-193a |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022543555A JP2022543555A (ja) | 2022-10-13 |
| JP2022543555A5 true JP2022543555A5 (https=) | 2023-03-10 |
Family
ID=69701219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022505487A Pending JP2022543555A (ja) | 2019-08-12 | 2020-03-06 | ｍｉＲＮＡ－１９３ａに関する新たな処置 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220275368A1 (https=) |
| EP (1) | EP4013869A1 (https=) |
| JP (1) | JP2022543555A (https=) |
| CN (1) | CN114729358A (https=) |
| AU (1) | AU2020327537A1 (https=) |
| CA (1) | CA3148713A1 (https=) |
| WO (1) | WO2021028081A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3976058A4 (en) * | 2019-06-03 | 2023-07-19 | Carmel-Haifa University Economic Corporation Ltd. | TREATMENT OF HEAD AND NECK CANCER IN HUMAN |
| AU2020327537A1 (en) * | 2019-08-12 | 2022-03-03 | Interna Technologies B.V. | New treatments involving miRNA-193a |
| CN114672558B (zh) * | 2021-12-29 | 2023-08-04 | 河北医科大学第三医院 | 肝癌药物仑伐替尼耐药机制的研究方法 |
| CN118678969A (zh) * | 2022-02-22 | 2024-09-20 | 株式会社食物流变功能研究所 | 抗癌剂及抗癌剂的筛选方法 |
| US20250333732A1 (en) * | 2022-05-23 | 2025-10-30 | Empirico Inc. | Treatment of sos2 related diseases and disorders |
| CN116850289B (zh) * | 2022-07-29 | 2025-10-28 | 东北大学 | Plk4靶向药物在治疗对铂类药物耐药型肿瘤中的应用 |
| CN117144008B (zh) * | 2023-08-31 | 2024-03-08 | 武汉科技大学 | 三阴性乳腺癌生物标志物及其应用 |
| WO2025111565A1 (en) * | 2023-11-22 | 2025-05-30 | Empirico Inc. | Treatment of sos2 related diseases and disorders |
| WO2025155574A1 (en) * | 2024-01-16 | 2025-07-24 | University Of Houston System, Board Of Regents | Modulation of akap12 signalosome |
| CN118671343B (zh) * | 2024-06-25 | 2025-04-29 | 南昌大学第一附属医院 | 一种头颈鳞状细胞癌分子标记物及其应用 |
| WO2026013165A1 (en) * | 2024-07-10 | 2026-01-15 | Université Libre de Bruxelles | Combination of ship2 inhibitor and plk1 inhibitor for use in the treatment of cancer |
| CN118987030B (zh) * | 2024-07-16 | 2025-05-30 | 广东医科大学附属医院 | 干预嗜碱性粒细胞exosc3在制备预防或治疗狼疮性肾炎药物中的应用 |
| CN119015428B (zh) * | 2024-10-29 | 2024-12-20 | 中国人民解放军总医院第三医学中心 | 一种敲低tmem91诱导肾癌细胞死亡和肿瘤免疫治疗肾癌的应用 |
| CN120989248B (zh) * | 2025-10-23 | 2025-12-23 | 山东第二医科大学 | 一种检测lncRNA标志物表达量的试剂在制备口腔鳞状细胞癌诊断产品或预后判断产品中的应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000000388A2 (en) | 1998-05-15 | 2000-01-06 | Tcs Engineering Services, Inc. | Enhanced aircraft cockpit configuration |
| US7220410B2 (en) | 2003-04-18 | 2007-05-22 | Galaxy Biotech, Llc | Monoclonal antibodies to hepatocyte growth factor |
| TWI476206B (zh) | 2003-07-18 | 2015-03-11 | Amgen Inc | 對肝細胞生長因子具專一性之結合劑 |
| FR2872704B1 (fr) | 2004-07-12 | 2007-11-02 | Laurent Schwartz | Pluritherapie contre le cancer |
| AR059922A1 (es) | 2006-04-01 | 2008-05-07 | Galaxy Biotech Llc | Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos |
| AU2007254853B2 (en) | 2006-06-02 | 2011-11-17 | Aveo Pharmaceuticals, Inc. | Hepatocyte growth factor (HGF) binding proteins |
| US7649083B2 (en) | 2006-06-02 | 2010-01-19 | Aveo Pharmaceuticals, Inc. | Hepatocyte growth factor (HGF) binding antibody |
| WO2008010558A1 (en) | 2006-07-20 | 2008-01-24 | Panasonic Corporation | Ultrasonic probe |
| WO2009091982A1 (en) | 2008-01-18 | 2009-07-23 | Alnylam Pharmaceuticals, Inc. | Mir-122 agonist |
| TW200948380A (en) | 2008-04-11 | 2009-12-01 | Galaxy Biotech Llc | Combination of HGF inhibitor and PTEN agonist to treat cancer |
| EP2591106A1 (en) * | 2010-07-06 | 2013-05-15 | InteRNA Technologies B.V. | Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
| US8691750B2 (en) | 2011-05-17 | 2014-04-08 | Axolabs Gmbh | Lipids and compositions for intracellular delivery of biologically active compounds |
| EP3369818B1 (en) | 2011-12-22 | 2021-06-09 | InteRNA Technologies B.V. | Mirna for treating head and neck cancer |
| US20160193252A1 (en) * | 2013-08-14 | 2016-07-07 | Reneuron Limited | STEM CELL MICROPARTICLES AND miRNA |
| US11446398B2 (en) * | 2016-04-11 | 2022-09-20 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
| WO2019106605A1 (en) | 2017-12-01 | 2019-06-06 | Board Of Regents, The University Of Texas System | Combination treatment for cancer |
| JP2021513508A (ja) * | 2018-02-12 | 2021-05-27 | インテアールエヌエー テクノロジーズ ビー．ヴイ．ＩｎｔｅＲＮＡ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｂ．Ｖ． | 抗がんマイクロｒｎａ及びその脂質製剤 |
| AU2020327537A1 (en) * | 2019-08-12 | 2022-03-03 | Interna Technologies B.V. | New treatments involving miRNA-193a |
| CN115461461A (zh) * | 2020-02-28 | 2022-12-09 | 因特尔纳技术有限公司 | 用于促进免疫原性细胞死亡的miRNA-193a |
-
2020
- 2020-03-06 AU AU2020327537A patent/AU2020327537A1/en not_active Abandoned
- 2020-03-06 US US17/630,457 patent/US20220275368A1/en not_active Abandoned
- 2020-03-06 CN CN202080070230.9A patent/CN114729358A/zh active Pending
- 2020-03-06 EP EP20707290.1A patent/EP4013869A1/en not_active Withdrawn
- 2020-03-06 WO PCT/EP2020/055965 patent/WO2021028081A1/en not_active Ceased
- 2020-03-06 JP JP2022505487A patent/JP2022543555A/ja active Pending
- 2020-03-06 CA CA3148713A patent/CA3148713A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543555A5 (https=) | ||
| JP2022508155A5 (https=) | ||
| Guo et al. | Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma | |
| JP7090034B2 (ja) | 化学療法、標的療法、光線力学療法、免疫療法及びそれらの任意の組み合わせのためのナノ粒子 | |
| JP6905075B2 (ja) | 腫瘍の治療または予防のための併用療法 | |
| US20250195641A1 (en) | Immunotherapeutic constructs and methods of their use | |
| CN111150853B (zh) | 一种肿瘤联合治疗药物载体的制备及应用 | |
| JP2015520143A5 (https=) | ||
| JP2017513931A (ja) | 超分子コンビナトリアル治療薬 | |
| JP2014520849A (ja) | 抗癌治療及び画像化並びに骨障害治療のための金属ビスホスホネートナノ粒子 | |
| JP2013543844A (ja) | 高分子コポリマーを含む治療用ナノ粒子 | |
| JP2018537403A5 (https=) | ||
| JP2004517045A5 (https=) | ||
| JP2015512943A5 (https=) | ||
| JP2013538213A5 (https=) | ||
| JP2014523413A5 (https=) | ||
| US10829427B2 (en) | Naphthoquinones, pro-drugs, and methods of use thereof | |
| JP6842779B2 (ja) | 二本鎖核酸分子、およびその用途 | |
| JP2023546316A5 (https=) | ||
| US9415011B1 (en) | Method for treatment of liver cancer and inhibition of metastasis with CXC-chemokine-receptor 4-targeted nanoparticle | |
| JP4814245B2 (ja) | 低酸素選択性抗腫瘍剤としてのスルホニルヒドラジンのリン酸含有プロドラッグ | |
| JP2022532923A5 (https=) | ||
| CN101268085A (zh) | 用于硼中子俘获治疗的硼化合物 | |
| JP2024521209A5 (https=) | ||
| JP2011500841A5 (https=) |